abil bacteria activ termin complement compon serum patient cystic fibrosi termin complement compon c3 c9 contribut host defens infect studi perform determin defect activ c3 c9 bacteria contribut pathogenesi recurr pulmonari infect cystic fibrosi bacteria incub serum patient cystic fibrosi 30 minut consumpt avail c3 sera control patient two patient chronic sever bronchiectasi base result present studi unlik defect activ c3 c9 contribut pathogenesi increas suscept pulmonari infect patient